The elevated levels of liver enzymes (ASL, ALT, and ALP) in our study suggest liver dysfunction, which may be indicative of nonalcoholic fatty liver disease (NAFLD). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.